Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001174789 | SCV001338127 | likely benign | not specified | 2020-01-31 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001183180 | SCV001348837 | likely benign | Cardiomyopathy | 2019-11-24 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002068127 | SCV002442222 | likely benign | Hypertrophic cardiomyopathy 2; Dilated cardiomyopathy 1D; Cardiomyopathy, familial restrictive, 3 | 2024-01-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002402524 | SCV002707574 | likely benign | Cardiovascular phenotype | 2020-08-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV003449569 | SCV004177969 | likely benign | Dilated cardiomyopathy 1D | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003449570 | SCV004177970 | likely benign | Cardiomyopathy, familial restrictive, 3 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003449568 | SCV004177971 | likely benign | Hypertrophic cardiomyopathy 2 | 2023-04-11 | criteria provided, single submitter | clinical testing |